| Table |
Browser
|
Adobe
|
|
|
|
Introduction |
|
|
| |
|
Author |
|
----
|
| |
|
References |
|
----
|
| |
|
Important Information for Users of This Pocket Guide |
|
----
|
| |
|
Abbreviations Used in This Pocket Guide |
|
----
|
|
1 |
Drug Information |
|
|
| |
|
Drug Table 1. Antiretroviral Agent Characteristics |
|
----
|
| |
|
Drug Table 2. Antiretroviral Agents, Class Adverse Reactions |
|
----
|
| |
|
Drug Table 3. Antiretroviral Agents, Adverse Reactions: “Black Box” Warnings |
|
----
|
| |
|
Drug Table 4. Combination Antiretroviral Therapy, Dose Adjustments |
|
----
|
| |
|
Drug Table 5. Drug Interactions: Contraindicated Combinations |
|
----
|
| |
|
Drug Table 6. Drug Interactions: Nucleosides |
|
----
|
| |
|
Drug Table 7. Drug Interactions: Combinations with PIs or NNRTIs Requiring Dose Modifications |
|
----
|
| 2 |
Antiretroviral Therapy |
|
|
| |
|
Adult ART Table 1. When to Start Therapy |
|
----
|
| |
|
Adult ART Table 2. Suggested Minimum Target Trough Levels |
|
----
|
| |
|
Adult ART Table 3. Starting Regimens for Antiretroviral Naïve Patients |
|
----
|
| |
|
Adult ART Table 4. Advantages and Disadvantages of Antiretroviral Regimens |
|
----
|
| |
|
Adult ART Table 5. Antiretroviral Regimens or Components That Are Not Generally Recommended |
|
----
|
| |
|
Adult ART Table 6. Laboratory Monitoring |
|
----
|
| |
|
Adult ART Table 7. Resistance Mutations |
|
----
|
| |
|
Therapeutic Failure |
|
----
|
| |
|
Adult ART Table 8.Methods to Achieve Readiness to Start HAART & Maintain Adherence |
|
----
|
| |
|
Adult ART Table 9. National Cholesterol Education Program: Indications for Dietary or Drug Therapy for Hyperlipidemia |
|
----
|
| |
|
Adult ART Table 10. Drug Therapy for Hyperlipidemia |
|
----
|
|
3 |
Pregnancy And HIV |
|
|
| |
|
Antiretroviral Therapy in Pregnancy |
|
----
|
| |
|
Pregnancy Table 1. Preferred Antiretroviral Agents |
|
----
|
| |
|
Pregnancy Table 2. Antiretroviral Agents: Pharmacokinetic and Toxicity Data |
|
----
|
| |
|
Pregnancy Table 3. Antiretroviral Drugs for Delivery |
|
----
|
| |
|
Pregnancy Table 4. Pregnancy Issues |
|
----
|
| |
|
Pregnancy Table 5. Clinical Scenarios and Management of Untreated Pregnant Patients Including C-Section |
|
----
|
| |
|
Pregnancy Table 6. Clinical Scenarios and Management of Treated Pregnant Patients Including C-Section |
|
----
|
| |
|
Pregnancy Table 7. Delivery Procedures and Therapy |
|
----
|
|
4 |
Prevention
Of HIV For Providers In Three Steps |
|
|
| |
|
Step 1. Screen Patients for Risk Behaviors |
|
----
|
| |
|
Step 2. Behavioral Interventions |
|
----
|
| |
|
Step 3. Partner Counseling and Notification |
|
----
|
| 5 |
Opportunistic Infections |
|
|
| |
|
Adult OI Table 1. 2001 USPHS/IDSA Guidelines for Prevention of Opportunistic Infections |
|
----
|
| |
|
Tuberculosis and HIV |
|
----
|
| |
|
Adult OI Table 2. Recommended Drug Regimens for Treatment of Latent TB in HIV Co-infected Adults |
|
----
|
| |
|
Adult OI Table 3. Monitoring of Patients on Latent TB Prophylaxis |
|
----
|
| |
|
Special Considerations for TB Treatment with HIV Co-infection |
|
----
|
| |
|
Adult OI Table 4.Treatment of Drug-Susceptible TB |
|
----
|
| |
|
Adult OI Table 5. Doses of Antituberculosis Drugs – First-line Drugs |
|
----
|
| |
|
Adult OI Table 6. Special Considerations for TB Treatment with HIV Co-infection |
|
----
|
|
6 |
Occupational HIV Postexposure Prophylaxis (PEP) |
|
|
| |
|
Considerations in Occupational Exposure to HIV |
|
----
|
| |
|
Occupational Postexposure Table 1. Exposure Contingencies |
|
----
|
| |
|
Occupational Postexposure Table 2. Indications for HIV PEP |
|
----
|
| |
|
Management of Health Care Workers (HCWs) With Potential HIV Exposure |
|
----
|
| |
|
Occupational Postexposure Table 3. Recommended Regimens |
|
----
|
| |
|
Resources for Consultation |
|
----
|
